Cyclo Therapeutics, Inc. Warrant
CYTHW
CYTHW was delisted on the 25th of March, 2025.
2 hedge funds and large institutions have $337K invested in Cyclo Therapeutics, Inc. Warrant in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 4 closing their positions.
67% less funds holding
Funds holding: 6 → 2 (-4)
84% less capital invested
Capital invested by funds: $2.05M → $337K (-$1.71M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$1.52M |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$208K |
| 3 |
AC
Armistice Capital
New York
|
-$156K |
| 4 |
CH
CVI Holdings
Wilmington,
Delaware
|
-$64K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3.27K |
CYTHW Hedge Fund Activity: Q1 2021 in Review
2 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Cyclo Therapeutics, Inc. Warrant (CYTHW) for Q1 2021, worth a combined $337K — down 84% from $2.05M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of CYTHW and 0 opened new positions — a net loss of 4 holders — while 1 trimmed existing stakes and 0 added.
The largest seller was AIGH Capital Management, exiting entirely with an estimated $1.52M sold.
- 2 institutional investors held Cyclo Therapeutics, Inc. Warrant (CYTHW) as of Q1 2021, down from 6 in Q4 2020.
- Funds reported $337K of Cyclo Therapeutics, Inc. Warrant stock for Q1 2021, down 84% quarter-over-quarter.
- 0 funds opened new Cyclo Therapeutics, Inc. Warrant positions in Q1 2021 and 4 closed out, a net change of -4 holders.
- The largest Cyclo Therapeutics, Inc. Warrant seller in Q1 2021 was AIGH Capital Management, an estimated $1.52M sold.
Based on aggregated 13F filings for Q1 2021.